Decreasing Nausea and Vomiting Due to Chemotherapy Induction Through Peppermint Aromatherapy by lestari, I. -. (indah)
49 
International Journal Of Nursing and Midwifery ,Volume1,Issue1,May-August2017 
© 2017 International Journal Of Nursing and Midwifery 
This is an Open Access article distributed under the terms of the Creative CommonsAttribution 
4.0 International License which permits unrestricted non-commercial use, distribution, and 
reproduction in any medium, provided the original work is properly cited. 
http://ijnms.net/index.php/ijnms 
ORIGINAL RESEARCH     
 
DECREASING NAUSEA AND VOMITING DUE TO CHEMOTHERAPY INDUCTION 
THROUGH PEPPERMINT AROMATHERAPY 
 
Indah Lestari*, Adji Khurniawan** 
Stikes Bina Sehat PPNI Mojokerto 
Email: ns.indah@yahoo.com , khurniawanadji@gmail.com 
 
ABSTRACT Keywords 
 
Nausea and vomiting often appear with under various conditions, including 
being a common side effect of using anti-neoplastic drugs. Chemotherapy-
induced nausea and vomiting (CINV) was a major problem that can often alter 
the quality of life (QoL) and patient adherence to treatment if left untreated. 
Aromatherapy peppermint is one form of improvised nonpharmacological 
handling of CINV. This study aims to determine the effectiveness of giving 
peppermint aromatherapy in reducing CINV. This study was a queasy 
experiment with Control Group design, with total sample groups of 285 
respondents with consecutive technique. Parameters in this study used Rhodes 
Index Nausea Vomiting and Reaching (RINVR). The data were analyzed using 
Wilcoxon sign rank test as a test of change of nausea scale of pre and post 
vomiting in experimental and control group. The results of the differences 
between both groups were tested with Mann Whitney-u test. Wilcoxon sign 
rank test analysis, showing differences in the incidence of nausea and vomiting. 
The result of a change of decrease in experimental group value ρ = 0,001 is 
more significant than the control group with value ρ = 0,020. The difference is 
tested with Mann Whitney-u test with the result value ρ = 0.002. Aromatherapy 
works in one’s body by triggering the release of neurotransmitter like 
enkephalin and endorphin which have an analgesic effect and increase the 
feeling of comfort and relax. Through inhalation, the fragrance of aromatherapy 
is transmitted through the limbic system into hypothalamus until pituitary and 
through the olfactory cortex, into thalamus and then head to the neocortex.  
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INTRODUCTION  
Vomiting or emesis is a condition due to 
strong intestinal muscle contraction that it 
pushes out the content of one’s stomach 
through their mouth. This condition occurs 
with or without being nauseous previously. 
Nausea and vomiting often present together 
in many conditions, including as a common 
side effect of chemotherapy, well known as 
chemotherapy-induced nausea and vomiting 
(CINV) (Pazdur, 2003). 
 
Nausea and vomiting are side effects which 
often occur after chemotherapy, and they 
can stay until 24 hours after the 
administration of chemotherapy drug 
(Smeltzer & Bare, 2002). High dose of IV 
(intravenous) Cisplatin and 
Cyclophosphamide can induce nausea and 
vomiting on more than 90% of the patients, 
compared to Bleomycin or Vincristine 
which can induce nausea and vomiting on 
less than 10% of the patients. (ASCO, 2016) 
 
CINV process is triggered by chemotherapy 
agents involving central nervous system, 
peripheral nerve, neurotransmitter, and 
receptors. Chemotherapy cytotoxic can 
damage gastrointestinal tract and trigger 
enterochromaffin cells (EC) to be 
distributed to the whole gastrointestinal wall 
to release nervous signals through 
neurotransmitter release, i.e., serotonin (5-
HT), substantial P (SP), dopamine (D2), 
monoamine (M), and histamine (H1). This 
neurotransmitter then enables afferent fibers 
of the vagus nerve by binding receptors (5-
HT3, NK-1, etc.) and afterward, it 
stimulates dorsal complex of vagus nerve 
consisting of emetic/vomiting center (VC) 
Chemoreceptor Trigger Zone (CTZ), and 
Nucleus Tractus Solitarius (NTS). The 
sensory is then integrated and leads to vomit 
response activation (Janelsins, 2013). 
 
The frequency of chemotherapy 
administration can lead to traumatic feeling 
if the respondent has a record of nausea and 
vomiting, this will cause the relapse of 
nausea and vomiting. According to Apfel, 
Kranke, and Eberhart (2004) nausea and 
vomiting record affect the relapse of nausea 
and vomiting in the coming condition. 
Paterson’s statement (2012) supported 
Hewitt and Watts opinion (2000) that 
nausea and vomiting record could enter a 
patient’s memory and bring about trauma 
and fear, this memory and fear will affect 
the performance of highest cortex center 
that induces the relapse of nausea and 
vomiting (Hewitt, 2009) 
 
According to Callaghan and Cheung's 
theory (2012), anxiety could affect the 
occurrence of nausea and vomiting. 
Anxiety condition triggers the increase of 
catecholamine plasma and air stack in the 
gastrointestinal tract; this will lead to 
gastric distention and trigger the occurrence 
of nausea and vomiting (Gundzik, 2008).  
     
The suggested actions to be taken to relieve 
nausea and vomiting complaint after 
chemotherapy among others is 
pharmacological therapy, i.e., anti-nausea 
and vomiting medicine before and after 
chemotherapy (pre-medication) and non-
pharmacological, i.e. conducive 
environment for being quiet and 
comfortable, nutrition intake arrangement, 
and relaxation (Abdul Muthalib in Sudoyo, 
2009).  
 
Cancer patient experiencing several 
chemotherapy-induced nausea and vomiting 
(CINV) may delay their chemotherapy 
session and refuse their coming treatment 
due to fear of nausea and vomiting 
(Mustian, 2011). Uncontrollable nausea and 
vomiting highly affect the whole patient’s 
therapy and influence therapy response as 
well as decrease cancer patient’s recovery 
level. Besides, uncontrollable nausea and 
vomiting can bring about dehydration, 
electrolytes imbalance, weight loss, and 
malnutrition. Extended vomiting could also 
lead to esophageal, gastric damage, and 
bleed (Pazdur, 2003). 
 
The occurrence of nausea and vomiting 
highly vary in chemotherapy cases that a 
good management for this disorder is 
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required for creating a rational therapy 
(appropriate, effective, safe, and 
convenient) as well as increasing the quality 
and life expectancy if cancer patients 
(ASCO, 2015). An inappropriate 
management of nausea and vomiting can 
hold the next chemotherapy process which 
may decrease cancer recovery rate, and 
trigger heavy anticipatory type of nausea 
and vomiting which has fear effect for 
chemotherapy patient (Grunberg, 2005). 
Pharmacological therapy is the main 
therapy. However, there are also several 
complementary and alternative therapies 
that can be used, i.e., herbal supplements in 
the form of aromatherapy that has been 
recommended by many to decrease CINV. 
This research proves the effectiveness of the 
use of peppermint aromatherapy against 
CINV. 
 
MATERIALS AND METHODS  
The design of this research was pre-
experimental with Quasi-Experiment – Non-
equivalent with control group design. The 
population of this research is all patients in 
chemotherapy ward at Mojokerto District  
Hospital, as many as 285 patients 
undergoing chemotherapy (135 respondents 
of the control group, 150 respondents of the 
experimental group). Data gathering before 
research suggested that the number of the 
population meeting the criteria was 325 
respondents. Sampling technique in this 
research was consecutive sampling, with 
inclusion criteria (Chemotherapy patients 
who experience nausea, no history of 
respiratory allergies, nasal function well, not 
pregnant, general condition good).  
 
Data gathering method consisted of 
administrative procedures. The research was 
conducted from 22nd of May 2016 to 2nd of 
June 2017. Measuring tool used is RINVR, 
Rodhes of Index Nausea, Vomiting, and 
Retching (RINVR) with eight assessment 
items (Characteristics of Nausea, Vomiting, 
and Retching; Time of Nausea, Vomiting, 
and Retching; Frequency of Nausea, 
Vomiting, and Retching in the last 12 
hours). Scores range from 0 to 32. With the 
assessment criteria: 0= not Nausea and 
Vomiting ; 1-8 = Lightweight; 9-16 = 
medium; 17-24 = heavy; 25-32 = bad 
(Rhodes & McDaniel, 2001). Respondents 
in experiment group were given peppermint 
aromatherapy oil which is dropped into a 
cotton ball as many as three drops, and they 
were asked for about 5 minutes. 
Respondents of control group will receive 
therapy as the hospital’s SOP. Peppermint 
therapy would not be given to respondents 
of control group; they only received 
pharmacological antiemetic therapy as a 
precaution for CINV. The therapy 
commonly used is ondansetron, 
diphenhydramine, and dexamethasone. 
 
Data analysis in this research used Wilcoxon 
signed ranks test; the analysis is used to 
know the change between two variables, and 
Mann Whitney-U test as difference test 
result between two groups. 
 
 
RESULTS  
The characteristics of those respondents are 
presented in a chart of frequency 
distribution and percentage as the 
followings: 
 
Table 1 Distribution of respondents by age, 
alcohol consumption history, disease 
diagnosis and chemotherapy cycle in the 
control group and experimental group at 
Mojokerto District Hospital  
N
O 
VARIABLE Control group Experimental group 
Frequenc
y 
Percentag
e 
Frequenc
y 
Percentag
e 
1. Age      
 21-30 0 0% 20 13% 
 31-40 18 13% 20 13% 
 41-50 18 13% 60 40% 
 51-60 54 40% 10 6% 
 61-70 45 33% 40 27% 
 TOTAL 135 100% 150 100% 
2. History of 
alcohol 
consumption 
    
 Ya  40 29% 20 13% 
 Tidak  95 71% 130 87% 
 TOTAL 135 100% 150 100% 
3. Medical 
diagnosis 
    
 Ca Liver 5 4% 0 0 
 Melanoma 4 3% 0 0 
 Limfoma  4 3% 0 0 
 Sarcoma  0 0 4 3% 
 Ca serviks 31 23% 26 17% 
 Ca paru 0 0 5 3% 
 Ca 0 0 9 6% 
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nasofaring 
 Ca Mammae 88 65% 100 7% 
 Ca colon 3 2% 6 4% 
 TOTAL 135 100% 150 100% 
4. Cycle of 
chemotherap
y 
    
 Cycle 1-2 85 63% 20 13% 
 Cycle 3-4 15 11% 75 50% 
 Cycle 5-6 15 11% 45 30% 
 Cycle 7-8 15 11% 10 7% 
 Cycle 9-10 3 2% 0 0 
 Cycle 11-12 2 1% 0 0 
 TOTAL 135 100% 150 100% 
 
The result of this research suggested that the 
average of respondent’s age is 51 years old 
and most respondents were women (81.3%). 
This result is in line with Bourdeanue’s 
research (2012) on 358 Asian women in 
California suffering from CINV, the average 
of patient’s age was 49 years old. While 
Santosh’s research (2011) on 30 patients 
receiving anti-cancer chemotherapy in India 
suggested that more than 50% of which 
were women (70%). 
Based on the table it was suggested that the 
majority of both experimental and control 
group never consume alcohol. Respondents 
who never consumed alcohol experienced 
more nausea, vomiting, vomiting more 
easily controlled in patients with a history of 
chronic alcohol (> 100 g / day) than patients 
with no history of alcohol. 
The majority of the experimental group 
were Ca Mammae. Based on the table it is 
known that the majority of respondents of 
the experimental group were on cycle 3 - 4 
and the majority of the control group were 
on cycle 1-2. Chemotherapy is the time 
required for the administration of 
chemotherapy. One cycle takes once every 3 
to 4 weeks, but there is also a cycle 
occurring every week (Tjokronegoro, 2006). 
Chemotherapy cycle affects nausea and 
vomiting symptoms. The more intense the 
chemotherapy is, the worse is nausea and 
the vomiting symptoms (McRonald & 
Leisher, 2005 in Marisa, 2014). 
 
Table 2 Distribution of respondents by type 
of chemotherapy-induced nausea vomiting 
in control group and experimental group at 
Mojokerto District Hospital 
 
N
O 
Type 
Nausea 
Vomiting 
Control Group Experimental group 
Frequen
cy 
Percenta
ge 
Frequen
cy 
Percenta
ge 
1. Acute  90 70% 100 70% 
2. Delayed 45 30% 50 30% 
3. Anticipato
ry  
0 0 0 0 
 TOTAL 135 100% 150 100% 
 
Based on nausea characteristics displayed on 
the table above, respondents suffering from 
acute nausea (70%) more with 90 
respondents suffering from delayed nausea 
(30%) as many as 45 respondents, while no 
respondents are experiencing anticipatory 
nausea (0%). 
 
Table 3 nausea and vomiting scale analysis 
of pre- and post-administration of 
peppermint aromatherapy in chemotherapy 
patients, the control group and the 
experimental group in Mojokerto District 
Hospital 
N
o  
Sca
le 
of 
nau
sea
- 
vo
mit
ing 
Control Group Experimental group 
  Pre Post Pre Post 
  Fre
que
ncy 
Perc
enta
ge 
Fre
que
ncy 
Perc
enta
ge 
Fre
que
ncy 
Perc
enta
ge 
Fre
que
ncy 
Perc
enta
ge 
1
. 
Not
hin
g 
0 0 9 7% 0 0 40 27% 
2
. 
Mil
d 
45 33% 45 33% 40 27% 60 40% 
3
. 
Me
diu
m 
36 27% 54 40% 30 20% 50 33% 
4
. 
Sev
ere  
36 27% 27 20% 60 40% 0 0 
5
. 
Ba
d  
18 13% 0 0 20 13% 0 0 
 TO
TA
L 
135 100
% 
135 100
% 
0 100
% 
0 100
% 
 Av
era
ge 
St. 
dev
iati
on 
p-
val
ue 
3.19 
1,04 
0.02 
2.75 
0,856 
z-value= -
2.333 
3.44 
1.031 
0.001 
2.13 
0.806 
z-value= -
3.391 
 
Results indicate that peppermint 
aromatherapy is effective against a decrease 
in the scale of nausea in chemotherapy 
patients, seen from the p-value of the 
experimental group (0.001) smaller than the 
control group(0.02). 
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DISCUSSION 
Chemotherapy-induced nausea and vomiting 
(CINV) are one of the side effects of 
chemotherapy that is often problematic can 
change the quality of life and adherence of 
patients to treatment, thereby reducing the 
rate of cure of cancer patients. Also, 
uncontrolled nausea vomiting can also cause 
dehydration, electrolyte imbalances, weight 
loss, and malnutrition. Prolonged vomiting 
can cause esophageal, gastric damage and 
bleed (Pazdur, 2003). 
 
The effectiveness of peppermint 
aromatherapy can be triggered by factors 
affecting the functions of the olfactory 
system. One of the most influential factors is 
age (Larsson in MUllol, 2012), conducting 
identification to the prevalence of anosmia 
to 75 respondents suggested that most of 
which were aged 60-69 years old (22.7%). 
The influence of age toward olfactory factor 
was also explained by Doty and Kamath 
(2014) through Cross-Sectional study 
suggested that half of the population in the 
United States age 65 - 80 years old 
experienced loss of olfactory function 
(Doty, 2014). 
 
Pharmacologically, fragrances from EO can 
deliver direct effects to a central nervous 
system and endocrine system unwittingly. 
While according to Geiger (2005 in Lua & 
Zakaria, 2012), they described that through 
inhalation, volatile molecules of EO 
passing olfactory receptor in the nose 
recognizing the molecular characteristics 
and send the signal to the brain through 
olfactory system. Besides, some main 
elements of the molecules enter the 
bloodstream through the lung and directly 
affect nerves in the brain after passing 
blood barrier in the brain. While 
Ondansetron works by blocking receptors 
in gastrointestinal and postrema area bound 
with serotonin in chemoreseptortrigerzone 
(CTZ) to medulla oblongata that it prevents 
nausea and vomiting reflect (Putri, 2010). 
 
Aromatherapy works in one’s body by 
triggering the release of neurotransmitter 
like enkephalin and endorphin which have 
an analgesic effect and increases the feeling 
of comfort and relax (Potts, 2009). Through 
inhalation, the fragrance of aromatherapy is 
transmitted through two ways, first is 
through the limbic system into 
hypothalamus until pituitary. Second is 
transmitted through the olfactory cortex, 
into thalamus and then head to the 
neocortex. Through these two ways, 
aromatherapy shall be processed until it 
creates the individual perception (Cook, 
2008). Hypothalamus acts as a relay and 
regulatory generating messages to be 
delivered to other parts of brain and body. 
The received messages shall be translated 
into action, i.e. releasing electrochemical 
substances that lead to euphoria (excessive 
pleasure), relaxation, and sedative. This 
limbic system is used mainly in emotional 
expression. One of the examples of 
perception expressed by an individual on 
inhaled peppermint aromatherapy is 
personal relaxation effect; this effect will 
decrease personal anxiety. The decrease of 
personal anxiety shall decrease the risk of 
nausea and vomiting incidences 
(Grunebaum, 2011). 
 
Some researchers have explained that 
peppermint aromatherapy is effective in 
decreasing nausea. Tayarani research result 
suggested that there was a significant 
decrease in the intensity and count of 
chemotherapy-induced nausea and vomiting 
within first 24 hours by using M. spicata 
and M. x. Piperita on both treatment groups 
compared to that of the control group 
(p<0.005) (Tayarani, 2013). Peppermint 
aromatherapy can also decrease nausea 
scale on Postoperative Nausea (PON) 
patients. Hunt’s research (2013) suggested 
that PON patient’s nausea scale decreased 
significantly (p>0.001) after a mixed EO of 
ginger, spearmint, peppermint, and 
cardamom is given (Hunt, 2013). A brief 
view concerning the use of aromatherapy 
for nausea vomiting by Lua and Zakaria 
(2012) suggested that of 5 articles meeting 
the criteria of inclusion which included 
experiments with 328 respondents, it is 
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suggested that the inhalation of peppermint 
essential oil (EO) vapor not only decreased 
the incidence and severity of nausea and 
vomiting but also decrease the use of 
antiemetic medicine and as a result increase 
patient’s satisfaction level.  
 
Several things analyzed by the researcher 
were that the giving of peppermint of 
aromatherapy would be more effective in 
decreasing nausea and vomiting and 
influence patient’s condition to be more 
relax as well as decreasing anxiety if 
conducted regularly and continuously 
maintained if the effects of aromatherapy 
fade out. Aromatic functions can be used to 
remove odor from a room as well as create 
a comfortable atmosphere in a room 
(Poerwadi, 2006). Thus, researchers added 
burning tools to every room if possible, as a 
combination to get a more optimum result. 
In this research, some chemotherapy 
respondents who were indicated for 
inpatient treatment that it made the 
researchers easier to focus and control the 
room’s environmental to get the optimum 
therapeutic effect. 
 
 
CONCLUSIONS 
Peppermint aromatherapy is effective on the 
decrease of the scale of chemotherapy-
induced nausea and vomiting (CINV).   
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